1996
DOI: 10.1111/j.1472-8206.1996.tb00303.x
|View full text |Cite
|
Sign up to set email alerts
|

The arterial wall: a new pharmacological and therapeutic target*

Abstract: In recent years, two key concepts having numerous interrelationships were advanced for the understanding of various cardiovascular diseases: the "endothelial dysfunction" and the "arterial remodelling". Both endothelial dysfunction and arterial remodelling occur in various pathologies including essential hypertension, heart failure, atherosclerosis, restenosis after angioplasty, and pulmonary hypertension, and have modified the therapeutic approach by offering new pharmacological targets: specific receptors no… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
7
0

Year Published

1997
1997
2008
2008

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(7 citation statements)
references
References 84 publications
0
7
0
Order By: Relevance
“…A central anatomical event in the arterial remodeling associated with the above conditions is the proliferation of local vascular smooth muscle. These mitotic events are stimulated by a variety of circulating hormones and growth factors [7][8][9] and the signaling that leads to this cell proliferation appears to require the activation of a cytosolic phospholipase A 2 (cPLA 2 ) [10,11]. We suggest that some of the pathological effects of Pb 2+ are due to interactions with the Ca 2+ -dependent signaling systems of various hormones and growth factors that involve the activation of cPLA 2 and result in the proliferation of vascular smooth muscle cells (VSMC).…”
Section: Introductionmentioning
confidence: 99%
“…A central anatomical event in the arterial remodeling associated with the above conditions is the proliferation of local vascular smooth muscle. These mitotic events are stimulated by a variety of circulating hormones and growth factors [7][8][9] and the signaling that leads to this cell proliferation appears to require the activation of a cytosolic phospholipase A 2 (cPLA 2 ) [10,11]. We suggest that some of the pathological effects of Pb 2+ are due to interactions with the Ca 2+ -dependent signaling systems of various hormones and growth factors that involve the activation of cPLA 2 and result in the proliferation of vascular smooth muscle cells (VSMC).…”
Section: Introductionmentioning
confidence: 99%
“…13 In contrast, large arteries undergo mainly hypertrophic remodeling, because their lumen size is generally not reduced, and wall thickness increases in an effort to compensate for the increased wall stress. 10,14 Chronic inhibition of NO synthesis with N G -nitro-Larginine methyl ester (L-NAME) leads to hypertension. Interestingly, in this model, small arteries undergo eutrophic remodeling in proportion to the elevation of arterial pressure.…”
mentioning
confidence: 99%
“…6,8 In hypertension, arteries adapt to the pressure-induced elevation in wall stress by changing their geometry. 9,10 Indeed, the elevated vascular resistance observed in hypertension is associated with an increased media thicknesslumen diameter ratio (remodeling) of resistance arteries. 11,12 In essential hypertension, the amount of material in the vessel wall is not augmented but appears to be rearranged around a smaller lumen, and the process has been called eutrophic remodeling.…”
mentioning
confidence: 99%
“…In atherosclerosis, the arterial neo-intima is the location of the formation of atherosclerotic plaques whereas CAVD disease commences within the boundaries of the valve and ultimately forces an expansion of the valve tissue [13]. Also, angiotensin receptors are expressed in VSMCs in the wall of normal vessels [14] but are not expressed by aortic valve myofibroblasts (avMs) in normal aortic valves [8].…”
Section: Introductionmentioning
confidence: 99%